These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16610922

  • 1. Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
    Marshall DA, Strauss ME, Pericak D, Buitendyk M, Codding C, Torrance GW.
    Am J Manag Care; 2006 Apr; 12(4):205-14. PubMed ID: 16610922
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D.
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [Abstract] [Full Text] [Related]

  • 7. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N, Furlong W, Perkins A, Feeny D, Torrance GW.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [Abstract] [Full Text] [Related]

  • 8. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG, Brown MM, Brown GC, Sharma S.
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach.
    Hass B, Lungershausen J, Hertel N, Poulsen Nautrup B, Kotowa W, Liedgens H.
    Eur J Health Econ; 2009 Jul; 10(3):309-21. PubMed ID: 19101743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
    Wielage RC, Bansal M, Andrews JS, Klein RW, Happich M.
    Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE.
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of intensive exercise therapy directly following hospital discharge in patients with arthritis: results of a randomized controlled clinical trial.
    Bulthuis Y, Mohammad S, Braakman-Jansen LM, Drossaers-Bakker KW, van de Laar MA.
    Arthritis Rheum; 2008 Feb 15; 59(2):247-54. PubMed ID: 18240191
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar 15; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 16. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C, Bojke L, Manca A, Adebajo A, Dickson J, Helliwell P, Morton V, Russell I, Torgerson D, Watson J.
    Rheumatology (Oxford); 2009 May 15; 48(5):558-63. PubMed ID: 19258378
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circumferential fusion is dominant over posterolateral fusion in a long-term perspective: cost-utility evaluation of a randomized controlled trial in severe, chronic low back pain.
    Soegaard R, Bünger CE, Christiansen T, Høy K, Eiskjaer SP, Christensen FB.
    Spine (Phila Pa 1976); 2007 Oct 15; 32(22):2405-14. PubMed ID: 18090078
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.